Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5185034, 7 pages
https://doi.org/10.1155/2017/5185034
Research Article

Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy

1Department of Internal Medicine, Pulmonology and Allergology, Medical University of Warsaw, Warsaw, Poland
2Laboratory of Flow Cytometry and Hematology, Department of Internal Medicine and Hematology, Military Medical Institute, Warsaw, Poland
3Department of Pathology, Pulmonary Hospital, Zakopane, Poland
4Department of Pathology, Medical University of Warsaw, Warsaw, Poland
5Department of Thoracic Surgery, Pulmonary Hospital, Zakopane, Poland

Correspondence should be addressed to Joanna Domagala-Kulawik; moc.liamg@kiwalukalagamod

Received 7 March 2017; Revised 20 June 2017; Accepted 5 July 2017; Published 2 August 2017

Academic Editor: Torsten Goldmann

Copyright © 2017 Joanna Domagala-Kulawik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. 2012, http://gco.iarc.fr/today/home.
  2. A. J. Alberg, M. V. Brock, J. G. Ford, J. M. Samet, and S. D. Spivack, “Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines,” Chest, vol. 143, no. 5, pp. 1S–29S, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Tartour and L. Zitvogel, “Lung cancer: Potential targets for immunotherapy,” The Lancet Respiratory Medicine, vol. 1, no. 7, pp. 551–563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Domagala-Kulawik, “The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention,” Translational Lung Cancer Research, vol. 4, no. 2, pp. 177–190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Brahmer, “PD-1-targeted immunotherapy: recent clinical findings,” Clinical Advances in Hematology & Oncology, vol. 10, pp. 674-675, 2012. View at Google Scholar
  6. J. Domagala-Kulawik, “Effects of cigarette smoke on the lung and systemic immunity,” Journal of Physiology and Pharmacology, vol. 59, supplement 6, pp. 19–34, 2008. View at Google Scholar
  7. B. Burkholder, R.-Y. Huang, R. Burgess et al., “Tumor-induced perturbations of cytokines and immune cell networks,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1845, no. 2, pp. 182–201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Krummey and M. L. Ford, “Braking bad: Novel mechanisms of CTLA-4 inhibition of T cell responses,” American Journal of Transplantation, vol. 14, no. 12, pp. 2685–2690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. V. C. Hegde and M. Liberman, “Mediastinal staging: endosonographic ultrasound lymph node biopsy or mediastinoscopy,” Thoracic Surgery Clinics, vol. 26, no. 3, pp. 243–249, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zieliński, “Transcervical Extended Mediastinal Lymphadenectomy,” Thoracic Surgery Clinics, vol. 20, no. 2, pp. 215–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Zieliński, Ł. Hauer, J. Hauer, J. Pankowski, A. Szlubowski, and T. Nabiałek, “Transcervical extended mediastinal lymphadenectomy (TEMLA) for staging of non-small-cell lung cancer (NSCLC),” Pneumonologia i Alergologia Polska, vol. 79, no. 3, pp. 196–206, 2011. View at Google Scholar · View at Scopus
  12. J. Galon, B. Mlecnik, G. Bindea et al., “Towards the introduction of the "Immunoscore" in the classification of malignant tumours,” Journal of Pathology, vol. 232, no. 2, pp. 199–209, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. U. Blank, J. B. Haanen, A. Ribas, and T. N. Schumacher, “The "cancer immunogram",” Science, vol. 352, no. 6286, pp. 658–660, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Donnem, S. M. Hald, E.-E. Paulsen et al., “Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer,” Clinical Cancer Research, vol. 21, no. 11, pp. 2635–2643, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ogino, J. Galon, C. S. Fuchs, and G. Dranoff, “Cancer immunology-analysis of host and tumor factors for personalized medicine,” Nature Reviews Clinical Oncology, vol. 8, no. 12, pp. 711–719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Senovilla, E. Vacchelli, J. Galon et al., “Trial watch: prognostic and predictive value of the immune infiltrate in cancer,” OncoImmunology, vol. 1, no. 8, pp. 1323–1343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Domagala-Kulawik, I. Osinska, and G. Hoser, “Mechanisms of immune response regulation in lung cancer,” Translational Lung Cancer Research, vol. 3, no. 1, pp. 15–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Osińska, A. Stelmaszczyk-Emmel, M. Polubiec-Kownacka, D. Dziedzic, and J. Domagała-Kulawik, “CD4+/CD25high/FoxP3+/CD127− regulatory T cells in bronchoalveolar lavage fluid of lung cancer patients,” Human Immunology, vol. 77, no. 10, pp. 912–915, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Hanagiri, Y. Shigematsu, S. Shinohara et al., “Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer,” Lung Cancer, vol. 81, no. 3, pp. 475–479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Shigematsu, T. Hanagiri, H. Shiota et al., “Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes,” Oncology Letters, vol. 4, no. 4, pp. 625–630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Tao, Y. Mimura, K. Aoe et al., “Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells,” Lung Cancer, vol. 75, no. 1, pp. 95–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. P. Petersen, M. J. Campa, J. Sperlazza et al., “Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients,” Cancer, vol. 107, no. 12, pp. 2866–2872, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Galon, F. Pagès, F. M. Marincola et al., “The immune score as a new possible approach for the classification of cancer,” Journal of Translational Medicine, vol. 10, no. 1, article 1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Diem, A. Magaret, A. Klock, L. Jin, J. Zhu, and L. Corey, “Image analysis for accurately counting CD4+ and CD8+ T cells in human tissue,” Journal of Virological Methods, vol. 222, pp. 117–121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Engelberg, R. T. Giberson, L. J. T. Young, N. E. Hubbard, and R. D. Cardiff, “The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixation,” Journal of Histochemistry and Cytochemistry, vol. 62, no. 5, pp. 319–334, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Engelberg, H. Retallack, R. Balassanian et al., “Score the Core Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring,” Human Pathology, vol. 46, no. 11, pp. 1694–1704, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yamazaki, Y. Nakamura, Y. Shibahara et al., “Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: Manual versus digital image analysis,” Human Pathology, vol. 53, pp. 41–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. K. M. Kerr, M.-S. Tsao, A. G. Nicholson, Y. Yatabe, I. I. Wistuba, and F. R. Hirsch, “Programmed death-ligand 1 immunohistochemistry in lung cancer: in what state is this art?” Journal of Thoracic Oncology, vol. 10, no. 7, pp. 985–989, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Schneider, S. Kimpfler, A. Warth et al., “Foxp3 + regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 432–438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Aerts and J. P. Hegmans, “Tumor-specific cytotoxic t cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer,” Cancer Research, vol. 73, no. 8, pp. 2381–2388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. A. Schalper, J. Brown, D. Carvajal-Hausdorf et al., “Objective measurement and clinical significance of TILs in non-small cell lung cancer,” Journal of the National Cancer Institute, vol. 107, no. 3, Article ID dju435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Wolf, S. Sopper, A. Pircher, G. Gastl, and A. M. Wolf, “Treg(s) in Cancer: Friends or Foe?” Journal of Cellular Physiology, vol. 230, no. 11, pp. 2598–2605, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Kwiecien, A. Stelmaszczyk-Emmel, M. Polubiec-Kownacka, D. Dziedzic, and J. Domagala-Kulawik, “Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans,” Cancer Immunology, Immunotherapy, vol. 66, no. 2, pp. 161–170, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Karanikas, M. Speletas, M. Zamanakou et al., “Foxp3 expression in human cancer cells,” Journal of Translational Medicine, vol. 6, article 19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Balsari, A. Merlo, P. Casalini et al., “FOXP3 expression and overall survival in breast cancer,” Journal of Clinical Oncology, vol. 27, no. 11, pp. 1746–1752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Liu, T. Zhang, J. Ye et al., “Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer,” Cancer Immunology, Immunotherapy, vol. 61, no. 10, pp. 1849–1856, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. W. D. Travis, E. Brambilla, M. Noguchi et al., “International association for the study of lung cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary,” Proceedings of the American Thoracic Society, vol. 8, no. 5, pp. 381–385, 2011. View at Publisher · View at Google Scholar · View at Scopus